Latest News and Press Releases

SEATTLE, WA--(Marketwired - Mar 29, 2017) - Atossa Genetics, Inc. (NASDAQ: ATOS), today announced the pricing of an underwritten public offering with anticipated gross proceeds of $4,000,000,...

SEATTLE, WA--(Marketwired - Mar 23, 2017) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has opened enrollment of a Phase 1 study of endoxifen, which is an active metabolite of...

SEATTLE, WA--(Marketwired - Jan 9, 2017) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it is transferring the site of its Phase 2 study of fulvestrant administered with its patented...

SEATTLE, WA--(Marketwired - Jan 5, 2017) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 9th annual Biotech...

SEATTLE, WA--(Marketwired - Dec 23, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Jack Cuzick, PhD, FRS, FMedSci, FRCP (hon), has been appointed as Scientific Advisor.  ...

SEATTLE, WA--(Marketwired - Dec 1, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 9th annual LD Micro Main...

SEATTLE, WA--(Marketwired - Nov 14, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced Third Quarter ended September 30, 2016 financial results and provided an update on recent company...

SEATTLE, WA--(Marketwired - Nov 10, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will provide a Company update and discuss third quarter 2016 financial results on Monday,...

SEATTLE, WA--(Marketwired - Oct 14, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS), today announced it would be a featured presenter at the SeeThru Equity Fall Microcap Investor Conference being...

SEATTLE, WA--(Marketwired - Sep 13, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced it has received notice from NASDAQ that Atossa has regained compliance with NASDAQ minimum...